Click for best price
OTC Transdermal Analgesic Patches Market Size, Share 2024
The global OTC Transdermal Analgesic Patches market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Lidocaine Patches Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of OTC Transdermal Analgesic Patches include Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo and Huarun 999, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Transdermal Analgesic Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Transdermal Analgesic Patches. This report contains market size and forecasts of OTC Transdermal Analgesic Patches in global, including the following market information:
Global OTC Transdermal Analgesic Patches Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global OTC Transdermal Analgesic Patches Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five OTC Transdermal Analgesic Patches companies in 2023 (%)
We surveyed the OTC Transdermal Analgesic Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OTC Transdermal Analgesic Patches Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global OTC Transdermal Analgesic Patches Market Segment Percentages, by Type, 2023 (%)
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Others
Global OTC Transdermal Analgesic Patches Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global OTC Transdermal Analgesic Patches Market Segment Percentages, by Application, 2023 (%)
Pharmacy
Clinic
Others
Global OTC Transdermal Analgesic Patches Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global OTC Transdermal Analgesic Patches Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OTC Transdermal Analgesic Patches revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies OTC Transdermal Analgesic Patches revenues share in global market, 2023 (%)
Key companies OTC Transdermal Analgesic Patches sales in global market, 2019-2024 (Estimated), (K Units)
Key companies OTC Transdermal Analgesic Patches sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu
Mylan
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
Actavis
Teikoku Seiyaku
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of OTC Transdermal Analgesic Patches, market overview.
Chapter 2: Global OTC Transdermal Analgesic Patches market size in revenue and volume.
Chapter 3: Detailed analysis of OTC Transdermal Analgesic Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OTC Transdermal Analgesic Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global OTC Transdermal Analgesic Patches capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
OTC Transdermal Analgesic Patches Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
120 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 OTC Transdermal Analgesic Patches Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global OTC Transdermal Analgesic Patches Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global OTC Transdermal Analgesic Patches Overall Market Size
2.1 Global OTC Transdermal Analgesic Patches Market Size: 2023 VS 2030
2.2 Global OTC Transdermal Analgesic Patches Revenue, Prospects & Forecasts: 2019-2030
2.3 Global OTC Transdermal Analgesic Patches Sales: 2019-2030
3 Company Landscape
3.1 Top OTC Transdermal Analgesic Patches Players in Global Market
3.2 Top Global OTC Transdermal Analgesic Patches Companies Ranked by Revenue
3.3 Global OTC Transdermal Analgesic Patches Revenue by Companies
3.4 Global OTC Transdermal Analgesic Patches Sales by Companies
3.5 Global OTC Transdermal Analgesic Patches Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 OTC Transdermal Analgesic Patches Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers OTC Transdermal Analgesic Patches Product Type
3.8 Tier 1, Tier 2 and Tier 3 OTC Transdermal Analgesic Patches Players in Global Market
3.8.1 List of Global Tier 1 OTC Transdermal Analgesic Patches Companies
3.8.2 List of Global Tier 2 and Tier 3 OTC Transdermal Analgesic Patches Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global OTC Transdermal Analgesic Patches Market Size Markets, 2023 & 2030
4.1.2 Lidocaine Patches
4.1.3 Diclofenac Patches
4.1.4 Indomethacin Patches
4.1.5 Counter-Irritant Patches
4.1.6 Others
4.2 By Type - Global OTC Transdermal Analgesic Patches Revenue & Forecasts
4.2.1 By Type - Global OTC Transdermal Analgesic Patches Revenue, 2019-2024
4.2.2 By Type - Global OTC Transdermal Analgesic Patches Revenue, 2025-2030
4.2.3 By Type - Global OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
4.3 By Type - Global OTC Transdermal Analgesic Patches Sales & Forecasts
4.3.1 By Type - Global OTC Transdermal Analgesic Patches Sales, 2019-2024
4.3.2 By Type - Global OTC Transdermal Analgesic Patches Sales, 2025-2030
4.3.3 By Type - Global OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
4.4 By Type - Global OTC Transdermal Analgesic Patches Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global OTC Transdermal Analgesic Patches Market Size, 2023 & 2030
5.1.2 Pharmacy
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global OTC Transdermal Analgesic Patches Revenue & Forecasts
5.2.1 By Application - Global OTC Transdermal Analgesic Patches Revenue, 2019-2024
5.2.2 By Application - Global OTC Transdermal Analgesic Patches Revenue, 2025-2030
5.2.3 By Application - Global OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
5.3 By Application - Global OTC Transdermal Analgesic Patches Sales & Forecasts
5.3.1 By Application - Global OTC Transdermal Analgesic Patches Sales, 2019-2024
5.3.2 By Application - Global OTC Transdermal Analgesic Patches Sales, 2025-2030
5.3.3 By Application - Global OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
5.4 By Application - Global OTC Transdermal Analgesic Patches Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global OTC Transdermal Analgesic Patches Market Size, 2023 & 2030
6.2 By Region - Global OTC Transdermal Analgesic Patches Revenue & Forecasts
6.2.1 By Region - Global OTC Transdermal Analgesic Patches Revenue, 2019-2024
6.2.2 By Region - Global OTC Transdermal Analgesic Patches Revenue, 2025-2030
6.2.3 By Region - Global OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
6.3 By Region - Global OTC Transdermal Analgesic Patches Sales & Forecasts
6.3.1 By Region - Global OTC Transdermal Analgesic Patches Sales, 2019-2024
6.3.2 By Region - Global OTC Transdermal Analgesic Patches Sales, 2025-2030
6.3.3 By Region - Global OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America OTC Transdermal Analgesic Patches Revenue, 2019-2030
6.4.2 By Country - North America OTC Transdermal Analgesic Patches Sales, 2019-2030
6.4.3 US OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.4.4 Canada OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.4.5 Mexico OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe OTC Transdermal Analgesic Patches Revenue, 2019-2030
6.5.2 By Country - Europe OTC Transdermal Analgesic Patches Sales, 2019-2030
6.5.3 Germany OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.5.4 France OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.5.5 U.K. OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.5.6 Italy OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.5.7 Russia OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.5.8 Nordic Countries OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.5.9 Benelux OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia OTC Transdermal Analgesic Patches Revenue, 2019-2030
6.6.2 By Region - Asia OTC Transdermal Analgesic Patches Sales, 2019-2030
6.6.3 China OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.6.4 Japan OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.6.5 South Korea OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.6.6 Southeast Asia OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.6.7 India OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America OTC Transdermal Analgesic Patches Revenue, 2019-2030
6.7.2 By Country - South America OTC Transdermal Analgesic Patches Sales, 2019-2030
6.7.3 Brazil OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.7.4 Argentina OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa OTC Transdermal Analgesic Patches Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa OTC Transdermal Analgesic Patches Sales, 2019-2030
6.8.3 Turkey OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.8.4 Israel OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.8.5 Saudi Arabia OTC Transdermal Analgesic Patches Market Size, 2019-2030
6.8.6 UAE OTC Transdermal Analgesic Patches Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Hisamitsu
7.1.1 Hisamitsu Company Summary
7.1.2 Hisamitsu Business Overview
7.1.3 Hisamitsu OTC Transdermal Analgesic Patches Major Product Offerings
7.1.4 Hisamitsu OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.1.5 Hisamitsu Key News & Latest Developments
7.2 Mylan
7.2.1 Mylan Company Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan OTC Transdermal Analgesic Patches Major Product Offerings
7.2.4 Mylan OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.2.5 Mylan Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Major Product Offerings
7.3.4 Johnson & Johnson OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Teva
7.4.1 Teva Company Summary
7.4.2 Teva Business Overview
7.4.3 Teva OTC Transdermal Analgesic Patches Major Product Offerings
7.4.4 Teva OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.4.5 Teva Key News & Latest Developments
7.5 Lingrui
7.5.1 Lingrui Company Summary
7.5.2 Lingrui Business Overview
7.5.3 Lingrui OTC Transdermal Analgesic Patches Major Product Offerings
7.5.4 Lingrui OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.5.5 Lingrui Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi OTC Transdermal Analgesic Patches Major Product Offerings
7.6.4 Sanofi OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.6.5 Sanofi Key News & Latest Developments
7.7 Qizheng
7.7.1 Qizheng Company Summary
7.7.2 Qizheng Business Overview
7.7.3 Qizheng OTC Transdermal Analgesic Patches Major Product Offerings
7.7.4 Qizheng OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.7.5 Qizheng Key News & Latest Developments
7.8 Endo
7.8.1 Endo Company Summary
7.8.2 Endo Business Overview
7.8.3 Endo OTC Transdermal Analgesic Patches Major Product Offerings
7.8.4 Endo OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.8.5 Endo Key News & Latest Developments
7.9 Huarun 999
7.9.1 Huarun 999 Company Summary
7.9.2 Huarun 999 Business Overview
7.9.3 Huarun 999 OTC Transdermal Analgesic Patches Major Product Offerings
7.9.4 Huarun 999 OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.9.5 Huarun 999 Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK OTC Transdermal Analgesic Patches Major Product Offerings
7.10.4 GSK OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.10.5 GSK Key News & Latest Developments
7.11 Haw Par
7.11.1 Haw Par Company Summary
7.11.2 Haw Par OTC Transdermal Analgesic Patches Business Overview
7.11.3 Haw Par OTC Transdermal Analgesic Patches Major Product Offerings
7.11.4 Haw Par OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.11.5 Haw Par Key News & Latest Developments
7.12 Nichiban
7.12.1 Nichiban Company Summary
7.12.2 Nichiban OTC Transdermal Analgesic Patches Business Overview
7.12.3 Nichiban OTC Transdermal Analgesic Patches Major Product Offerings
7.12.4 Nichiban OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.12.5 Nichiban Key News & Latest Developments
7.13 Laboratoires Genevrier
7.13.1 Laboratoires Genevrier Company Summary
7.13.2 Laboratoires Genevrier OTC Transdermal Analgesic Patches Business Overview
7.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Major Product Offerings
7.13.4 Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.13.5 Laboratoires Genevrier Key News & Latest Developments
7.14 BLUE-EMU
7.14.1 BLUE-EMU Company Summary
7.14.2 BLUE-EMU Business Overview
7.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Major Product Offerings
7.14.4 BLUE-EMU OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.14.5 BLUE-EMU Key News & Latest Developments
7.15 IBSA Group
7.15.1 IBSA Group Company Summary
7.15.2 IBSA Group Business Overview
7.15.3 IBSA Group OTC Transdermal Analgesic Patches Major Product Offerings
7.15.4 IBSA Group OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.15.5 IBSA Group Key News & Latest Developments
7.16 Pfizer
7.16.1 Pfizer Company Summary
7.16.2 Pfizer Business Overview
7.16.3 Pfizer OTC Transdermal Analgesic Patches Major Product Offerings
7.16.4 Pfizer OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.16.5 Pfizer Key News & Latest Developments
7.17 Performance Health
7.17.1 Performance Health Company Summary
7.17.2 Performance Health Business Overview
7.17.3 Performance Health OTC Transdermal Analgesic Patches Major Product Offerings
7.17.4 Performance Health OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.17.5 Performance Health Key News & Latest Developments
7.18 Actavis
7.18.1 Actavis Company Summary
7.18.2 Actavis Business Overview
7.18.3 Actavis OTC Transdermal Analgesic Patches Major Product Offerings
7.18.4 Actavis OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.18.5 Actavis Key News & Latest Developments
7.19 Teikoku Seiyaku
7.19.1 Teikoku Seiyaku Company Summary
7.19.2 Teikoku Seiyaku Business Overview
7.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Major Product Offerings
7.19.4 Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.19.5 Teikoku Seiyaku Key News & Latest Developments
7.20 Novartis
7.20.1 Novartis Company Summary
7.20.2 Novartis Business Overview
7.20.3 Novartis OTC Transdermal Analgesic Patches Major Product Offerings
7.20.4 Novartis OTC Transdermal Analgesic Patches Sales and Revenue in Global (2019-2024)
7.20.5 Novartis Key News & Latest Developments
8 Global OTC Transdermal Analgesic Patches Production Capacity, Analysis
8.1 Global OTC Transdermal Analgesic Patches Production Capacity, 2019-2030
8.2 OTC Transdermal Analgesic Patches Production Capacity of Key Manufacturers in Global Market
8.3 Global OTC Transdermal Analgesic Patches Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 OTC Transdermal Analgesic Patches Supply Chain Analysis
10.1 OTC Transdermal Analgesic Patches Industry Value Chain
10.2 OTC Transdermal Analgesic Patches Upstream Market
10.3 OTC Transdermal Analgesic Patches Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 OTC Transdermal Analgesic Patches Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of OTC Transdermal Analgesic Patches in Global Market
Table 2. Top OTC Transdermal Analgesic Patches Players in Global Market, Ranking by Revenue (2023)
Table 3. Global OTC Transdermal Analgesic Patches Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global OTC Transdermal Analgesic Patches Revenue Share by Companies, 2019-2024
Table 5. Global OTC Transdermal Analgesic Patches Sales by Companies, (K Units), 2019-2024
Table 6. Global OTC Transdermal Analgesic Patches Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers OTC Transdermal Analgesic Patches Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers OTC Transdermal Analgesic Patches Product Type
Table 9. List of Global Tier 1 OTC Transdermal Analgesic Patches Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 OTC Transdermal Analgesic Patches Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global OTC Transdermal Analgesic Patches Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global OTC Transdermal Analgesic Patches Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global OTC Transdermal Analgesic Patches Sales (K Units), 2019-2024
Table 15. By Type - Global OTC Transdermal Analgesic Patches Sales (K Units), 2025-2030
Table 16. By Application ? Global OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global OTC Transdermal Analgesic Patches Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global OTC Transdermal Analgesic Patches Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global OTC Transdermal Analgesic Patches Sales (K Units), 2019-2024
Table 20. By Application - Global OTC Transdermal Analgesic Patches Sales (K Units), 2025-2030
Table 21. By Region ? Global OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global OTC Transdermal Analgesic Patches Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global OTC Transdermal Analgesic Patches Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global OTC Transdermal Analgesic Patches Sales (K Units), 2019-2024
Table 25. By Region - Global OTC Transdermal Analgesic Patches Sales (K Units), 2025-2030
Table 26. By Country - North America OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America OTC Transdermal Analgesic Patches Sales, (K Units), 2019-2024
Table 29. By Country - North America OTC Transdermal Analgesic Patches Sales, (K Units), 2025-2030
Table 30. By Country - Europe OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe OTC Transdermal Analgesic Patches Sales, (K Units), 2019-2024
Table 33. By Country - Europe OTC Transdermal Analgesic Patches Sales, (K Units), 2025-2030
Table 34. By Region - Asia OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia OTC Transdermal Analgesic Patches Sales, (K Units), 2019-2024
Table 37. By Region - Asia OTC Transdermal Analgesic Patches Sales, (K Units), 2025-2030
Table 38. By Country - South America OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America OTC Transdermal Analgesic Patches Sales, (K Units), 2019-2024
Table 41. By Country - South America OTC Transdermal Analgesic Patches Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa OTC Transdermal Analgesic Patches Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa OTC Transdermal Analgesic Patches Sales, (K Units), 2025-2030
Table 46. Hisamitsu Company Summary
Table 47. Hisamitsu OTC Transdermal Analgesic Patches Product Offerings
Table 48. Hisamitsu OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Hisamitsu Key News & Latest Developments
Table 50. Mylan Company Summary
Table 51. Mylan OTC Transdermal Analgesic Patches Product Offerings
Table 52. Mylan OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Mylan Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson OTC Transdermal Analgesic Patches Product Offerings
Table 56. Johnson & Johnson OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Teva Company Summary
Table 59. Teva OTC Transdermal Analgesic Patches Product Offerings
Table 60. Teva OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Teva Key News & Latest Developments
Table 62. Lingrui Company Summary
Table 63. Lingrui OTC Transdermal Analgesic Patches Product Offerings
Table 64. Lingrui OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Lingrui Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi OTC Transdermal Analgesic Patches Product Offerings
Table 68. Sanofi OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Sanofi Key News & Latest Developments
Table 70. Qizheng Company Summary
Table 71. Qizheng OTC Transdermal Analgesic Patches Product Offerings
Table 72. Qizheng OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Qizheng Key News & Latest Developments
Table 74. Endo Company Summary
Table 75. Endo OTC Transdermal Analgesic Patches Product Offerings
Table 76. Endo OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Endo Key News & Latest Developments
Table 78. Huarun 999 Company Summary
Table 79. Huarun 999 OTC Transdermal Analgesic Patches Product Offerings
Table 80. Huarun 999 OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Huarun 999 Key News & Latest Developments
Table 82. GSK Company Summary
Table 83. GSK OTC Transdermal Analgesic Patches Product Offerings
Table 84. GSK OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. GSK Key News & Latest Developments
Table 86. Haw Par Company Summary
Table 87. Haw Par OTC Transdermal Analgesic Patches Product Offerings
Table 88. Haw Par OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Haw Par Key News & Latest Developments
Table 90. Nichiban Company Summary
Table 91. Nichiban OTC Transdermal Analgesic Patches Product Offerings
Table 92. Nichiban OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Nichiban Key News & Latest Developments
Table 94. Laboratoires Genevrier Company Summary
Table 95. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product Offerings
Table 96. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Laboratoires Genevrier Key News & Latest Developments
Table 98. BLUE-EMU Company Summary
Table 99. BLUE-EMU OTC Transdermal Analgesic Patches Product Offerings
Table 100. BLUE-EMU OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. BLUE-EMU Key News & Latest Developments
Table 102. IBSA Group Company Summary
Table 103. IBSA Group OTC Transdermal Analgesic Patches Product Offerings
Table 104. IBSA Group OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. IBSA Group Key News & Latest Developments
Table 106. Pfizer Company Summary
Table 107. Pfizer OTC Transdermal Analgesic Patches Product Offerings
Table 108. Pfizer OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. Pfizer Key News & Latest Developments
Table 110. Performance Health Company Summary
Table 111. Performance Health OTC Transdermal Analgesic Patches Product Offerings
Table 112. Performance Health OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. Performance Health Key News & Latest Developments
Table 114. Actavis Company Summary
Table 115. Actavis OTC Transdermal Analgesic Patches Product Offerings
Table 116. Actavis OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 117. Actavis Key News & Latest Developments
Table 118. Teikoku Seiyaku Company Summary
Table 119. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product Offerings
Table 120. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 121. Teikoku Seiyaku Key News & Latest Developments
Table 122. Novartis Company Summary
Table 123. Novartis OTC Transdermal Analgesic Patches Product Offerings
Table 124. Novartis OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 125. Novartis Key News & Latest Developments
Table 126. OTC Transdermal Analgesic Patches Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 127. Global OTC Transdermal Analgesic Patches Capacity Market Share of Key Manufacturers, 2021-2024
Table 128. Global OTC Transdermal Analgesic Patches Production by Region, 2019-2024 (K Units)
Table 129. Global OTC Transdermal Analgesic Patches Production by Region, 2025-2030 (K Units)
Table 130. OTC Transdermal Analgesic Patches Market Opportunities & Trends in Global Market
Table 131. OTC Transdermal Analgesic Patches Market Drivers in Global Market
Table 132. OTC Transdermal Analgesic Patches Market Restraints in Global Market
Table 133. OTC Transdermal Analgesic Patches Raw Materials
Table 134. OTC Transdermal Analgesic Patches Raw Materials Suppliers in Global Market
Table 135. Typical OTC Transdermal Analgesic Patches Downstream
Table 136. OTC Transdermal Analgesic Patches Downstream Clients in Global Market
Table 137. OTC Transdermal Analgesic Patches Distributors and Sales Agents in Global Market
List of Figures
Figure 1. OTC Transdermal Analgesic Patches Segment by Type in 2023
Figure 2. OTC Transdermal Analgesic Patches Segment by Application in 2023
Figure 3. Global OTC Transdermal Analgesic Patches Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global OTC Transdermal Analgesic Patches Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global OTC Transdermal Analgesic Patches Revenue, 2019-2030 (US$, Mn)
Figure 7. OTC Transdermal Analgesic Patches Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by OTC Transdermal Analgesic Patches Revenue in 2023
Figure 9. By Type - Global OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 11. By Type - Global OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 12. By Type - Global OTC Transdermal Analgesic Patches Price (US$/Unit), 2019-2030
Figure 13. By Application - Global OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 15. By Application - Global OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 16. By Application - Global OTC Transdermal Analgesic Patches Price (US$/Unit), 2019-2030
Figure 17. By Region - Global OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global OTC Transdermal Analgesic Patches Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 20. By Region - Global OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 21. By Country - North America OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 22. By Country - North America OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 23. US OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 24. Canada OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 27. By Country - Europe OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 28. Germany OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 29. France OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 31. Italy OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 32. Russia OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 36. By Region - Asia OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 37. China OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 38. Japan OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 41. India OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 43. By Country - South America OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 44. Brazil OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa OTC Transdermal Analgesic Patches Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa OTC Transdermal Analgesic Patches Sales Market Share, 2019-2030
Figure 48. Turkey OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 49. Israel OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 51. UAE OTC Transdermal Analgesic Patches Revenue, (US$, Mn), 2019-2030
Figure 52. Global OTC Transdermal Analgesic Patches Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production OTC Transdermal Analgesic Patches by Region, 2023 VS 2030
Figure 54. OTC Transdermal Analgesic Patches Industry Value Chain
Figure 55. Marketing Channels
